Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02933879 · ClinicalTrials.gov registry record · Phase 2
Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical Study
A Phase 2 study, sponsored by Sun Pharmaceutical Industries.
- Completed
- Registry status
- Phase 2
- Development phase
- 184
- Enrollment target
NCT02933879 is a Phase 2 study that has completed, run by Sun Pharmaceutical Industries. The registered enrollment target is 184 participants.
The verdict
NCT02933879, a Phase 2 study, has completed, sponsored by Sun Pharmaceutical Industries.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 184 participants
- Enrollment target
Study Summary
A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi- Site Phase 2b Clinical Study to Assess the Efficacy, Safety and Tolerability of 8-Week Regimens of NVXT topical product in Patients with Mild to Moderate Onychomycosis
Interventions
- DRUG NVXT topical
- DRUG Placebo (Vehicle) Topical
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 184 participants |
| Start Date | 2016-03-21 |
| Est. Completion | 2018-06-21 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02933879
The ClinicalTrials.gov registry entry for NCT02933879 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 184 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sun Pharmaceutical Industries, which has 48 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which NVXT topical is the first listed.
NCT02933879 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02933879 about?
NCT02933879 is a clinical study titled "Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical Study". A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi- Site Phase 2b Clinical Study to Assess the Efficacy, Safety and Tolerability of 8-Week Regimens of NVXT topical product in Patients with Mild to Moderate Onychomycosis
What is the current status of trial NCT02933879?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 184 participants. The study started on 2016-03-21. Estimated completion is 2018-06-21.
What interventions are being tested in trial NCT02933879?
The interventions under investigation include: NVXT topical (DRUG), Placebo (Vehicle) Topical (DRUG).
Who is sponsoring clinical trial NCT02933879?
This trial is sponsored by Sun Pharmaceutical Industries, which has 48 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.